OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.

Registration to our newsletter is FREE, Join today by entering your email below!

Tag Archives: ACTC

Advanced Cell Technology, Inc. (OTCBB: ACTC) Continuing to Move Forward with Clinical Trials for dry AMD and Stargardt’s

Posted on August 3, 2012 by Editor

After a relatively slow start to the week trading volume in Advanced Cell Technology, Inc. (OTCBB: ACTC) is closing strong as Friday has already seen more than 8.1 million shares move hands, this following Thursday’s impressive volume that reached 8.5 … Continue reading →

Posted in Uncategorized | Tagged , , , , , , | Leave a comment

Advanced Cell Technology, Inc. (OTCBB: ACTC) Trumpeting Early Success of Retinal Implants but Plenty of Roadblocks Remain in Their Path

Posted on January 23, 2012 by Editor

Advanced Cell Technology, Inc. (OTCBB: ACTC) is seeing massive activity on Monday following a report that two patients who had received embryonic stem cells in the form of retinal implants to treat diseases of the eye were doing well four … Continue reading →

Posted in Uncategorized | Tagged , , , , , , | Leave a comment

Advanced Cell Technology, Inc. (OTCBB: ACTC) Presents Investors with the Ultimate High Risk High Reward Gamble

Posted on November 8, 2011 by Editor

With high risk comes high reward and for those investors who believe in Advanced Cell Technology, Inc. (OTCBB: ACTC) the very chance that the biotechnology company will navigate their way through financial uncertainty and legal hurdles is worth a shot, … Continue reading →

Posted in Articles, OTC Bulletin Board, Penny Stocks | Tagged , , , , , , , | Leave a comment

Advanced Cell Technology (OTCBB: ACTC) Remains Attractive Option for Investors Looking at Biotechnology Stocks with Bright Future

Posted on July 26, 2011 by Editor

While the moral debate concerning the use of human embryonic stem cells (hESCs) as the foundation for regenerative medicine remains as heated as ever there are few who question the legitimate medical benefits of the controversial subject. With so much … Continue reading →

Posted in Uncategorized | Tagged , , , , , , , , , | Leave a comment

How Will U.S. Court Decision to Block Federal Funding of Embryonic Stem Cell Research Affect Advanced Cell Technology Stock

Posted on August 24, 2010 by OTC Equity

Late Monday afternoon a U.S. district court in Washington issued a preliminary injunction stopping federal funding of human embryonic stem cell research, casting a shadow of doubt in the minds of investors concerning biotechnology companies specializing in the controversial field of regenerative medicine. Continue reading →

Posted in Articles, OTC Bulletin Board, Penny Stocks, Stocks to Watch | Tagged , , , , | Leave a comment